WG
PFE icon

Winchester Group’s Pfizer PFE Stock Holding History

Winchester Group’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		$3.27M Sell
119,983
-56,040
-32% -$1.52M 0.72% 43
2013
Q2 		$4.68M Buy
+176,023
New +$4.86M 1% 21

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Winchester Group's PFE Position: Q3 2013 in Review

Winchester Group reduced its Pfizer (PFE) stake by 32% in Q3 2013, selling an estimated $1.52M and leaving 119,983 shares worth $3.27M. The position accounts for 0.72% of the portfolio, ranked #43.

Winchester Group first reported a position in PFE in Q2 2013 and has held it in 2 quarters since. The position peaked at $4.68M in Q2 2013. 1,606 funds tracked by Wall St. Rank hold PFE as of Q3 2013.

  • Winchester Group held 119,983 shares of Pfizer worth $3.27M as of Q3 2013.
  • Winchester Group sold 56,040 Pfizer shares in Q3 2013, an estimated $1.52M.
  • Pfizer made up 0.72% of Winchester Group's portfolio in Q3 2013, its #43 holding.
  • Winchester Group first reported a position in Pfizer in Q2 2013 and has held it in 2 quarters since.
  • Winchester Group's Pfizer position peaked at $4.68M in Q2 2013.
  • 1,606 funds tracked by Wall St. Rank held Pfizer as of Q3 2013.

Based on Winchester Group's 13F filing for Q3 2013, filed 16 Oct 2013.